Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation
Authors:
- 1 April 2008
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 21 (4) , 314-319
Abstract
Lung transplantation (LTx) is a therapeutic option for patients with end-stage lung disease. However, the mortality rate of patients on the waiting list is high. The purpose of this study was to examine the prognostic value of cardio-pulmonary hemodynamics for death in patients awaiting LTx. Retrospectively, 177 patients with advanced lung disease accepted for LTx at Sahlgrenska University Hospital from January 1990 through December 2003 were studied. Patient demographics, pulmonary function tests, gas exchange and hemodynamic variables were included in the analysis. Death while awaiting LTx was the primary endpoint for all analyses. Mean age was 49 +/- 9 years. Main diagnoses were alpha 1 antitrypsin deficiency (n = 56), chronic obstructive pulmonary disease (n = 61), cystic fibrosis (n = 14) and interstitial lung disease (n = 46). Thirty patients died (17%). LTx was performed in 143 cases. By univariate analyses, forced vital capacity (FVC) % of predicted, pulmonary vascular resistance (PVR) and diagnosis were associated with risk for death. In multivariate analysis PVR (HR, 1.22; 95% CI, 1.06-1.41; P = 0.006) and FVC% of predicted (HR, 0.97; 95% CI, 0.94-0.99; P = 0.01) were independently associated with death. Patients with increased PVR and a lower FVC % of predicted awaiting LTx should be considered for a higher organ allocation priority. Assessment of pulmonary hemodynamics needs to be considered during evaluation for LTx.Keywords
This publication has 20 references indexed in Scilit:
- Update in Pulmonary Hypertension 2005American Journal of Respiratory and Critical Care Medicine, 2006
- Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary FibrosisChest, 2006
- Waiting for a thoracic transplant in Eurotransplant*Transplant International, 2006
- Lung Transplantation in Patients With Chronic Obstructive Pulmonary Disease in a National Cohort Is Without Obvious Survival BenefitThe Journal of Heart and Lung Transplantation, 2006
- Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2005
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJACC, 2002
- Assessment of survival benefit after lung transplantation by patient diagnosisThe Journal of Heart and Lung Transplantation, 2002
- Predicting Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Standardization of Spirometry, 1994 Update. American Thoracic SocietyAmerican Journal of Respiratory and Critical Care Medicine, 1995